The normative questions in this list require careful analysis of the moral considerations involved. However, development of policies regarding these issues may be informed in a variety of ways by the views of key stakeholders: patients, family members, healthcare professionals, and the general public. Although reports of attitudes and intentions do not always foreshadow actual behavior, they provide a window into the thinking of those persons most likely to be impacted by the spread of genetic testing for psychiatric disorders. Data on stakeholders’ views can indicate a need for targeted education, identify areas in which regulation may be necessary, and generally indicate in which direction the moral sentiments of key portions of the population tend. Hence, there are sound reasons to explore attitudes and beliefs about genetic testing among relevant groups.
